I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Schnadig, Ian
31
results:
Search for persons
X
Format
Online (31)
Mediatypes
Articles (Online) (18)
OpenAccess-fulltext (13)
Sorted by: Relevance
Sorted by: Year
?
1
Phase Ib/II Study of Enzalutamide with Samotolisib (LY30234..:
Sweeney, Christopher J.
;
Percent, Ivor J.
;
Babu, Sunil
...
Clinical Cancer Research. 28 (2022) 11 - p. 2237-2247 , 2022
Link:
https://doi.org/10.1158/..
?
2
Safety and Efficacy of Nivolumab in Patients With Advanced ..:
Vogelzang, Nicholas J.
;
Olsen, Mark R.
;
McFarlane, Joshua J.
...
Clinical Genitourinary Cancer. 18 (2020) 6 - p. 461-468.e3 , 2020
Link:
https://doi.org/10.1016/..
?
3
Safety and Efficacy of Nivolumab in Patients With Advanced ..:
McFarlane, Joshua J.
;
Kochenderfer, Mark D.
;
Olsen, Mark R.
...
Clinical Genitourinary Cancer. 18 (2020) 6 - p. 469-476.e4 , 2020
Link:
https://doi.org/10.1016/..
?
4
Recent developments in the clinical pharmacology of rolapit..:
Rapoport, Bernardo
;
Aapro, Matti
;
Chasen, Martin
...
Drug Design, Development and Therapy. 11 (2017) - p. 2621-2629 , 2017
Link:
https://doi.org/10.2147/..
?
5
APF530 versus ondansetron, each in a guideline-recommended ..:
Schnadig, Ian
;
Agajanian, Richy
;
Dakhil, Christopher
...
Cancer Management and Research. 9 (2017) - p. 179-187 , 2017
Link:
https://doi.org/10.2147/..
?
6
Efficacy of the neurokinin‐1 receptor antagonist rolapitant..:
Hesketh, Paul J.
;
Schnadig, Ian D.
;
Schwartzberg, Lee S.
...
Cancer. 122 (2016) 15 - p. 2418-2425 , 2016
Link:
https://doi.org/10.1002/..
?
7
Rolapitant improves quality of life of patients receiving h..:
Chasen, Martin
;
Urban, Laszlo
;
Schnadig, Ian
...
Supportive Care in Cancer. 25 (2016) 1 - p. 85-92 , 2016
Link:
https://doi.org/10.1007/..
?
8
A Randomized, Phase II Trial of Cetuximab With or Without P..:
Bowles, Daniel W.
;
Kochenderfer, Mark
;
Cohn, Allen
...
Clinical Colorectal Cancer. 15 (2016) 4 - p. 337-344.e2 , 2016
Link:
https://doi.org/10.1016/..
?
9
Efficacy and safety of rolapitant for prevention of chemoth..:
Rapoport, Bernardo
;
Schwartzberg, Lee
;
Chasen, Martin
...
European Journal of Cancer. 57 (2016) - p. 23-30 , 2016
Link:
https://doi.org/10.1016/..
?
10
Treatment of CD30-positive systemic mastocytosis with brent..:
Borate, Uma
;
Mehta, Amitkumar
;
Reddy, Vishnu
...
Leukemia Research. 44 (2016) - p. 25-31 , 2016
Link:
https://doi.org/10.1016/..
?
11
Sequencing of Cabazitaxel and Abiraterone Acetate After Doc..:
Sonpavde, Guru
;
Bhor, Menaka
;
Hennessy, Daniel
...
Clinical Genitourinary Cancer. 13 (2015) 4 - p. 309-318 , 2015
Link:
https://doi.org/10.1016/..
?
12
A randomized, phase 2 trial of docetaxel with or without PX..:
Jimeno, Antonio
;
Bauman, Julie E.
;
Weissman, Charles
...
Oral Oncology. 51 (2015) 4 - p. 383-388 , 2015
Link:
https://doi.org/10.1016/..
?
13
Clinical outcomes with bevacizumab-containing and non-bevac..:
Chen, Clara
;
Ravelo, Arliene
;
Yu, Elaine
..
Journal of Neuro-Oncology. 122 (2015) 3 - p. 595-605 , 2015
Link:
https://doi.org/10.1007/..
?
14
Dosing Patterns, Toxicity, and Outcomes in Patients Treated..:
Schnadig, Ian D.
;
Hutson, Thomas E.
;
Chung, Hsingwen
...
Clinical Genitourinary Cancer. 12 (2014) 6 - p. 413-421 , 2014
Link:
https://doi.org/10.1016/..
?
15
Light Chain Renal Amyloidosis With Prominent Giant Cells:
Troxell, Megan L.
;
Griffiths, Ryan
;
Schnadig, Ian
.
American Journal of Kidney Diseases. 62 (2013) 6 - p. 1193-1197 , 2013
Link:
https://doi.org/10.1053/..
1-15